Invention Grant
- Patent Title: Method for activating helper T cell
-
Application No.: US13877768Application Date: 2011-10-04
-
Publication No.: US10654892B2Publication Date: 2020-05-19
- Inventor: Haruo Sugiyama , Shinji Sogo , Masayoshi Sato , Ryuki Kitamoto , Yoshihiro Goto
- Applicant: Haruo Sugiyama , Shinji Sogo , Masayoshi Sato , Ryuki Kitamoto , Yoshihiro Goto
- Applicant Address: JP Suita-shi JP Tokyo
- Assignee: International Institute of Cancer Immunology, Inc.,OTSUKA PHARMACEUTICAL CO., LTD.
- Current Assignee: International Institute of Cancer Immunology, Inc.,OTSUKA PHARMACEUTICAL CO., LTD.
- Current Assignee Address: JP Suita-shi JP Tokyo
- Agency: Oblon, McClelland, Maier & Neustadt, L.L.P.
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@24be75e5
- International Application: PCT/JP2011/072874 WO 20111004
- International Announcement: WO2012/046730 WO 20120412
- Main IPC: A61K39/00
- IPC: A61K39/00 ; C12N5/0783 ; C07K7/08 ; C07K14/82 ; A61K35/17
Abstract:
The present invention relates to a method for activating helper T cells, which includes the step of activating helper T cells by adding a WT1 peptide to antigen presenting cells, wherein the WT1 peptide has the ability to bind to any MHC class II molecule of an HLA-DRB1*0101 molecule, an HLA-DRB1*0401 molecule, an HLA-DRB1*0403 molecule, an HLA-DRB1*0406 molecule, an HLA-DRB1*0803 molecule, an HLA-DRB1*0901 molecule, an HLA-DRB1*1101 molecule, an HLA-DRB3*0202 molecule, an HLA-DRB4*0101 molecule, an HLA-DPB1*0201 molecule or an HLA-DPB1*0301 molecule, and the like.
Public/Granted literature
- US20130266958A1 METHOD FOR ACTIVATING HELPER T CELL Public/Granted day:2013-10-10
Information query
